3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
115
Recruiting
76
Terminated
58
Active not recruiting
42
Withdrawn
11
Unknown
11
Not yet recruiting
6
Suspended
2
Enrolling by invitation
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Head & Neck
4
Thoracic
2
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
21
Lung Neoplasms
17
Neoplasms
7
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
4
Small Cell Lung Carcinoma
4
Mesothelioma
4
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Mesothelioma, Malignant
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
NSCLC
2
Melanoma
2
Endometrial Neoplasms
2
Diabetes Mellitus
2
Carcinoma, Transitional Cell
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Stomach Neoplasms
1
Psoriasis
1
Post-Lyme Disease Syndrome
1
Pneumonia
1
Parkinson Disease
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Obsessive-Compulsive Disorder
1
Neoplasms, Squamous Cell
1
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Suspended
×
Squamous Cell Carcinoma of Head and Neck
×
Thoracic
×
Clear all
NCT04266730
2026-04-23
PANDA-VAC
UNC Lineberger Comprehensive Cancer Center
Phase 1
Suspended
6 enrolled
NCT03253575
2019-04-08
ANCERS-2
Mitra RxDx, Inc.
Suspended
800 enrolled